Questcor Pharmaceuticals, Inc. (QCOR) Message Board
-
2013 Stock of the Year?
Amarantus Bioscience - AMBS
The company's MANF technology may hold a cure for Parkinson's disease.
Read the recent Yahoo news.
One of the co-founders of Amgen recently invested in the company and became a member of its board of directors.-
Down 70% from its recent high of .20.
Substantially oversold. -
The "Brain Mapping Program" will make the company's patented MANF technology invaluable.
-
Buy a few shares today for under six cents.
- 1 Reply to scanit2008
-
6-centz iz a betta deal dan Q wuz when I bot fo 80-centz yeahz ago, aye Bozz?
-
"Big pharma" partnership in 2013 takes it over $1.00.
-
Opportunity to get in now for under five cents.
$1.00 within six months is realistic.
Due diligence.
-
37.340.48(+1.30%)May 17 4:00 PMEDT